Advisory Board Archives | Curadigm https://curadigm.elementi-design.com/team-category/advisory-board/ Together To Reshape Healthcare Mon, 02 Mar 2020 17:21:20 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.4 https://curadigm.elementi-design.com/wp-content/uploads/2019/12/cropped-curadigm-icon_512x512-32x32.png Advisory Board Archives | Curadigm https://curadigm.elementi-design.com/team-category/advisory-board/ 32 32 Jeff HRKACH https://curadigm.elementi-design.com/our-team/#advisory-board https://curadigm.elementi-design.com/our-team/#advisory-board#respond Mon, 16 Dec 2019 11:56:42 +0000 https://www.curadigm.com/?post_type=team&p=280 Jeff Hrkach is Senior Vice President of Technology Development at Frequency Therapeutics, leading the CMC, pharmaceutical development and delivery research efforts. Jeff joined Frequency from Moderna, where he was Head of Delivery Innovation. Prior to Moderna, Jeff held several senior leadership positions, including Chief Technology Officer, at BIND Therapeutics. Jeff made his postdoctoral research with Pr. Robert Langer at MIT and has over 25 peer-reviewed scientific publications and more than 50 U.S. patents/applications. He received his Ph.D. in Chemistry and M.S. in Polymer Science from Carnegie Mellon University and his B.S. in Chemistry from the Philadelphia College of Pharmacy and Science.

The post Jeff HRKACH appeared first on Curadigm.

]]> Jeff Hrkach is Senior Vice President of Technology Development at Frequency Therapeutics, leading the CMC, pharmaceutical development and delivery research efforts. Jeff joined Frequency from Moderna, where he was Head of Delivery Innovation. Prior to Moderna, Jeff held several senior leadership positions, including Chief Technology Officer, at BIND Therapeutics. Jeff made his postdoctoral research with Pr. Robert Langer at MIT and has over 25 peer-reviewed scientific publications and more than 50 U.S. patents/applications. He received his Ph.D. in Chemistry and M.S. in Polymer Science from Carnegie Mellon University and his B.S. in Chemistry from the Philadelphia College of Pharmacy and Science.

The post Jeff HRKACH appeared first on Curadigm.

]]> https://curadigm.elementi-design.com/our-team/#advisory-board/feed/ 0 Patrick TRICOLI https://curadigm.elementi-design.com/our-team/#advisory-board https://curadigm.elementi-design.com/our-team/#advisory-board#respond Mon, 16 Dec 2019 11:56:16 +0000 https://www.curadigm.com/?post_type=team&p=278 Patrick Tricoli is CEO of Nanobiotix Corp. and has been appointed Global Head of Business Development of Nanobiotix. Patrick has over 25 years’ experience within the pharmaceutical industry. He joins Nanobiotix from Sanofi where he held a number of positions in both Corporate and Research and Development. Patrick has focused on international business development and partnering activities. He is a doctor of Pharmaceutical Sciences, he holds a master degree in Pharmacology and Pharmacokinetics, and he is an Executive MBA from ESCP Europe.

The post Patrick TRICOLI appeared first on Curadigm.

]]> Patrick Tricoli is CEO of Nanobiotix Corp. and has been appointed Global Head of Business Development of Nanobiotix. Patrick has over 25 years’ experience within the pharmaceutical industry. He joins Nanobiotix from Sanofi where he held a number of positions in both Corporate and Research and Development. Patrick has focused on international business development and partnering activities. He is a doctor of Pharmaceutical Sciences, he holds a master degree in Pharmacology and Pharmacokinetics, and he is an Executive MBA from ESCP Europe.

The post Patrick TRICOLI appeared first on Curadigm.

]]> https://curadigm.elementi-design.com/our-team/#advisory-board/feed/ 0